Owens & Minor Inc. Aktie
Neueste Einschätzungen
Deine Einschätzung
Owens & Minor Inc. Aktie
Was spricht für und gegen Owens & Minor Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Owens & Minor Inc. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Owens & Minor Inc. | -1,71 % | -2,82 % | -28,93 % | 1,18 % | -1,71 % | -33,95 % | - |
Orasure Tech | 5,80 % | -6,14 % | -11,40 % | -28,72 % | -36,38 % | -37,50 % | -36,98 % |
scPharmaceuticals | - | -4,61 % | -11,54 % | -57,76 % | -28,00 % | -10,00 % | - |
SI-BONE Inc | -2,84 % | 3,79 % | -4,86 % | -34,76 % | -27,89 % | -45,20 % | - |
Kommentare
News
Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024
Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution
Owens & Minor Reports First Quarter 2024 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2024.
Key Highlights:
-
Consolidated revenue of $2.6 billion in the first quarter
Owens & Minor Announces First Quarter 2024 Earnings Release Date and Conference Call
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2024 on Friday, May 3, 2024, before trading begins on the New York Stock Exchange.
The Company will